相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A Phase 2/3 Trial of Pabinafusp Alfa, IDS Fused with Anti-Human Transferrin Receptor Antibody, Targeting Neurodegeneration in MPS-II
Torayuki Okuyama et al.
MOLECULAR THERAPY (2021)
Spinal manifestations of CLN1 disease start during the early postnatal period
H. R. Nelvagal et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2021)
Current Clinical Applications of In Vivo Gene Therapy with AAVs
Jerry R. Mendell et al.
MOLECULAR THERAPY (2021)
The Genetic Basis of Phenotypic Heterogeneity in the Neuronal Ceroid Lipofuscinoses
Emily Gardner et al.
FRONTIERS IN NEUROLOGY (2021)
Management of CLN1 Disease: International Clinical Consensus
Erika F. Augustine et al.
PEDIATRIC NEUROLOGY (2021)
Gene therapy for neurological disorders: challenges and recent advancements
Stefanie A. Pena et al.
JOURNAL OF DRUG TARGETING (2020)
Peroxisomal Dysfunction in Neurological Diseases and Brain Aging
Ndidi-Ese Uzor et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2020)
CNS-Targeting Therapies for Lysosomal Storage Diseases: Current Advances and Challenges
Mariola J. Edelmann et al.
FRONTIERS IN MOLECULAR BIOSCIENCES (2020)
Current and Emerging Treatment Strategies for Neuronal Ceroid Lipofuscinoses
Alfried Kohlschuetter et al.
CNS DRUGS (2019)
Mitochondrial dysfunction in neurodegenerative diseases and the potential countermeasure
Yan Wang et al.
CNS NEUROSCIENCE & THERAPEUTICS (2019)
Therapeutic landscape for Batten disease: current treatments and future prospects
Tyler B. Johnson et al.
NATURE REVIEWS NEUROLOGY (2019)
CRISPR/Cas9 mediated generation of an ovine model for infantile neuronal ceroid lipofuscinosis (CLN1 disease)
S. L. Eaton et al.
SCIENTIFIC REPORTS (2019)
Clinical challenges and future therapeutic approaches for neuronal ceroid lipofuscinosis
Sara E. Mole et al.
LANCET NEUROLOGY (2019)
Longitudinal In Vivo Monitoring of the CNS Demonstrates the Efficacy of Gene Therapy in a Sheep Model of CLN5 Batten Disease
Nadia L. Mitchell et al.
MOLECULAR THERAPY (2018)
Study of Intraventricular Cerliponase Alfa for CLN2 Disease
Angela Schulz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Computation of a High-Resolution MRI 3D Stereotaxic Atlas of the Sheep Brain
Arsene Ella et al.
JOURNAL OF COMPARATIVE NEUROLOGY (2017)
Synergistic effects of treating the spinal cord and brain in CLN1 disease
Charles Shyng et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Engineering of GlcNAc-1-Phosphotransferase for Production of Highly Phosphorylated Lysosomal Enzymes for Enzyme Replacement Therapy
Lin Liu et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2017)
Manifestation of neuronal ceroid lipofuscinosis in Australian Merino sheep: Observations on altered behaviour and growth
Greg M. Cronin et al.
APPLIED ANIMAL BEHAVIOUR SCIENCE (2016)
Intrathecal enzyme replacement therapy improves motor function and survival in a preclinical mouse model of infantile neuronal ceroid lipofuscinosis
Jui-Yun Lu et al.
MOLECULAR GENETICS AND METABOLISM (2015)
Nonclinical evaluation of CNS-administered TPP1 enzyme replacement in canine CLN2 neuronal ceroid lipofuscinosis
Brian R. Vuillemenot et al.
MOLECULAR GENETICS AND METABOLISM (2015)
Enzyme Replacement Therapy Attenuates Disease Progression in a Canine Model of Late-Infantile Neuronal Ceroid Lipofuscinosis (CLN2 Disease)
Martin L. Katz et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2014)
Gene Therapy for the Nervous System: Challenges and New Strategies
Casey A. Maguire et al.
NEUROTHERAPEUTICS (2014)
Genetic basis and phenotypic correlations of the neuronal ceroid lipofusinoses
Varun Warrier et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2013)
Regional Brain Atrophy in Mouse Models of Neuronal Ceroid Lipofuscinosis: A New Rostrocaudal Perspective
Thomas G. Kuehl et al.
JOURNAL OF CHILD NEUROLOGY (2013)
Intravenous high-dose enzyme replacement therapy with recombinant palmitoyl-protein thioesterase reduces visceral lysosomal storage and modestly prolongs survival in a preclinical mouse model of infantile neuronal ceroid lipofuscinosis
Jie Hu et al.
MOLECULAR GENETICS AND METABOLISM (2012)
Intrathecal tripeptidyl-peptidase 1 reduces lysosomal storage in a canine model of late infantile neuronal ceroid lipofuscinosis
Brian R. Vuillemenot et al.
MOLECULAR GENETICS AND METABOLISM (2011)
Human recombinant palmitoyl-protein thioesterase-1 (PPT1) for preclinical evaluation of enzyme replacement therapy for infantile neuronal ceroid lipofuscinosis
Jui-Yun Lu et al.
MOLECULAR GENETICS AND METABOLISM (2010)
Cerebellar pathology and motor deficits in the palmitoyl protein thioesterase 1-deficient mouse
Shannon L. Macauley et al.
EXPERIMENTAL NEUROLOGY (2009)
Intraventricular enzyme replacement improves disease phenotypes in a mouse model of late infantile neuronal ceroid lipofuscinosis
Michael Chang et al.
MOLECULAR THERAPY (2008)
Successive neuron loss in the thalamus and cortex in a mouse model of infantile neuronal ceroid lipofuscinosis
Catherine Kielar et al.
NEUROBIOLOGY OF DISEASE (2007)
Gene therapy for lysosomal storage diseases
Mark S. Sands et al.
MOLECULAR THERAPY (2006)
AAV2-Mediated ocular gene therapy for infantile neuronal ceroid lipofuscinosis
M Griffey et al.
MOLECULAR THERAPY (2005)
Neuroradiological findings (MRS, MRI, SPECT) in infantile neuronal ceroid-lipofuscinosis (infantile CLN1) at differenet stages of the disease
SL Vanhanen et al.
NEUROPEDIATRICS (2004)
Adeno-associated virus 2-mediated gene therapy decreases autofluorescent storage material and increases brain mass in a murine model of infantile neuronal ceroid lipofuscinosis
M Griffey et al.
NEUROBIOLOGY OF DISEASE (2004)
Disruption of PPT1 or PPT2 causes neuronal ceroid lipofuscinosis in knockout mice
P Gupta et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
分享论文
